91 related articles for article (PubMed ID: 10987024)
1. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
Ernst-Stecken A
Strahlenther Onkol; 2000 Aug; 176(8):383-4. PubMed ID: 10987024
[No Abstract] [Full Text] [Related]
2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
3. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
[TBL] [Abstract][Full Text] [Related]
4. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
Nathan CO; Liu L; Li BD; Abreo FW; Nandy I; De Benedetti A
Oncogene; 1997 Jul; 15(5):579-84. PubMed ID: 9247311
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
7. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer.
Hiller DJ; Chu Q; Meschonat C; Panu L; Burton G; Li BD
J Surg Res; 2009 Oct; 156(2):265-9. PubMed ID: 19665145
[TBL] [Abstract][Full Text] [Related]
10. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.
Berkel HJ; Turbat-Herrera EA; Shi R; de Benedetti A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):663-6. PubMed ID: 11401917
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
Abouhashem NS; Elwan A; Elaidy NF
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
[TBL] [Abstract][Full Text] [Related]
12. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
[TBL] [Abstract][Full Text] [Related]
13. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
15. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
16. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
[TBL] [Abstract][Full Text] [Related]
17. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
18. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
Hussein MR; Cullen K
Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
[TBL] [Abstract][Full Text] [Related]
19. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
[TBL] [Abstract][Full Text] [Related]
20. Selective reporting biases in cancer prognostic factor studies.
Kyzas PA; Loizou KT; Ioannidis JP
J Natl Cancer Inst; 2005 Jul; 97(14):1043-55. PubMed ID: 16030302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]